| Macrophages, inflammation, and lung cancer EM Conway, LA Pikor, SHY Kung, MJ Hamilton, S Lam, WL Lam, ... American journal of respiratory and critical care medicine 193 (2), 116-130, 2016 | 260 | 2016 |
| Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis EA Marshall, KW Ng, SHY Kung, EM Conway, VD Martinez, EC Halvorsen, ... Molecular cancer 15, 1-15, 2016 | 193 | 2016 |
| Proteomic screens for suppressors of anoikis identify IL1RAP as a promising surface target in Ewing sarcoma HF Zhang, CS Hughes, W Li, JZ He, D Surdez, AM El-Naggar, H Cheng, ... Cancer discovery 11 (11), 2884-2903, 2021 | 51 | 2021 |
| Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrence KSS Enfield, SD Martin, EA Marshall, SHY Kung, P Gallagher, K Milne, ... Journal for immunotherapy of cancer 7, 1-13, 2019 | 49 | 2019 |
| Microtubule affinity‐regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non‐small cell lung cancer R Hubaux, KL Thu, EA Vucic, LA Pikor, SHY Kung, VD Martinez, ... International journal of cancer 137 (9), 2072-2082, 2015 | 47 | 2015 |
| Deregulation of small non-coding RNAs at the DLK1-DIO3 imprinted locus predicts lung cancer patient outcome KSS Enfield, VD Martinez, EA Marshall, GL Stewart, SHY Kung, ... Oncotarget 7 (49), 80957, 2016 | 42 | 2016 |
| Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling D Nath, X Li, C Mondragon, D Post, M Chen, JR White, ... Cell Communication and Signaling 17, 1-19, 2019 | 38 | 2019 |
| Dynamic phase separation of the androgen receptor and its coactivators key to regulate gene expression F Zhang, M Biswas, S Massah, J Lee, S Lingadahalli, S Wong, C Wells, ... Nucleic Acids Research 51 (1), 99-116, 2023 | 37 | 2023 |
| SLFN5 regulates LAT1-mediated mTOR activation in castration-resistant prostate cancer RS Martinez, MJ Salji, L Rushworth, C Ntala, GR Blanco, A Hedley, ... Cancer Research, 2021 | 22 | 2021 |
| Determination of urinary prostaglandin E2 as a potential biomarker of ureteral stent associated inflammation ZA Huang, KB Scotland, Y Li, J Tan, SHY Kung, BH Chew, DDY Chen, ... Journal of Chromatography B 1145, 122107, 2020 | 19 | 2020 |
| THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer A Blomme, C Peter, E Mui, G Rodriguez Blanco, N An, LM Mason, ... EMBO molecular medicine 14 (3), e14764, 2022 | 14 | 2022 |
| EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities O Yedier-Bayram, B Gokbayrak, A Kayabolen, AC Aksu, AD Cavga, ... Cell Death & Disease 13 (8), 1-11, 2022 | 10 | 2022 |
| Uropathogens Preferrentially Interact with Conditioning Film Components on the Surface of Indwelling Ureteral Stents Rather than Stent Material KB Scotland, SHY Kung, BH Chew, D Lange Pathogens 9 (9), 764, 2020 | 10 | 2020 |
| The HACE1 E3 ligase mediates RAC1‐dependent control of mTOR signaling complexes B Turgu, A El‐Naggar, M Kogler, L Tortola, HF Zhang, M Hassan, ... EMBO reports 24 (12), e56815, 2023 | 3 | 2023 |
| A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma L Ramos, S Truong, B Zhai, J Joshi, F Ghaidi, MM Lizardo, T Shyp, ... Clinical Cancer Research 29 (17), 3541-3553, 2023 | 3 | 2023 |
| DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2 R Kaarijärvi, H Kaljunen, L Nappi, L Fazli, SHY Kung, JM Hartikainen, ... Communications Biology 7 (1), 108, 2024 | 2 | 2024 |
| Indwelling stents cause obstruction and induce ureteral injury and fibrosis in a porcine model KB Scotland, K Almutairi, E Park, L Wang, SHY Kung, A Haegert, ... BJU international 131 (3), 367-375, 2023 | 2 | 2023 |
| P2. 01-065 Quantification of Tumor-Immune Cell Spatial Relationships in the Lung Tumor Microenvironment Using Single Cell Profiling: Topic: Immune Mechanisms in Thoracic Cancer … K Enfield, S Kung, P Gallagher, K Milne, Z Chen, D Piga, S Lam, J English, ... Journal of Thoracic Oncology 12 (1), S826-S827, 2017 | 2 | 2017 |
| P2. 01-024 Expression of miR-106 Paralogs Improves Prognostic Value of Mesenchymal Signatures but Only miR-106b Promotes Invasiveness: Topic: Analysis of RNA S Kung, K Enfield, D Rowbotham, E Marshall, A Holly, C Pastrello, ... Journal of Thoracic Oncology 12 (1), S799, 2017 | 2 | 2017 |
| Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic) 2-like protein (ASH2L) as a regulator of glioblastoma cell survival E Ozyerli-Goknar, EY Kala, AC Aksu, I Bulut, A Cingöz, S Nizamuddin, ... Cell Communication and Signaling 21 (1), 328, 2023 | 1 | 2023 |
